Surrozen has announced a strategic shift in its pipeline, transitioning its Wnt signaling expertise ...
read more
Unity Biotechnology has announced topline results from its Phase 2b ASPIRE clinical trial, evaluatin...
read more
Bausch + Lomb has released new findings from a Phase 4 clinical study evaluating Miebo (perfluorohex...
read more
Opthea Limited has announced that its global Phase 3 clinical trial, known as COAST (Combination OPT...
read more
ZEISS Medical Technology has announced the Canadian availability of its advanced VISULAS® Combi lase...
read more
Alcon has announced a definitive merger agreement to acquire Lensar, Inc., marking a significant exp...
read more
The Glaucoma Research Foundation has named nine researchers as recipients of its 2025 Shaffer Resear...
read more
Kalaris Therapeutics and AlloVir Inc. have finalized their merger, forming a new entity under the Ka...
read more
Formosa Pharmaceuticals has signed an exclusive licensing agreement with Cipla for the commercializa...
read more
Ocugen has received clearance from its Data and Safety Monitoring Board (DSMB) to proceed with the s...
read more
More
